tirzepatide gip glp 1 dual action drops 💊 Tirzepatide — Mechanism of

The activation of microglia and astrocytes lead to the accumulation of cytokines, NF-B pathway activation, and oxidative damage to proteins

Tirzepatide (weekly injection) is a dual GIP/GLP-1 agonist that may produce even greater results

Common side effects include: Gastrointestinal issues: Nausea, vomiting, constipation, and abdominal pain Injection site reactions: Redness, swelling, and pain Systemic issues: Fatigue, indigestion, heartburn, belching, and hair loss More severe side effects include: Thyroid problems: Medullary thyroid cancer and pancreatitis with severe, persistent abdominal pain Gallbladder problems with symptoms such as upper abdominal pain, fever, jaundice, or clay-colored stools Increased risk of hypoglycemia with symptoms such as dizziness, sweating, confusion, and shakiness Severe vomiting that leads to dehydration and kidney problems Mental health concerns such as depression and suicidal thoughts Vision changes from rapid changes in blood glucose levels Some patients should not use Zepbound, such as those who have or are at risk for medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Those two conflicting theories are illustrated in Fig

These associations have sparked growing interest in repurposing antidiabetic drugs, particularly those that target insulin signaling, as potential disease-modifying therapies for PD

It also lowers HbA1C and protects cells of the cardiovascular and nervous systems by reducing inflammation and apoptosis